MyAverix Finance
F · Healthcare
GABATHER AB (PUBL) SK-44 (5J2)
Drug Manufacturers - Specialty & Generic
GABATHER AB (PUBL) SK-44 (5J2) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 5J2
GABATHER AB (PUBL) SK-44 (5J2) — FAQ
What is 5J2's P/E ratio?
The price-to-earnings (P/E) ratio for GABATHER AB (PUBL) SK-44 (5J2) is 18.00 (data as of 2026-05-23).
Does GABATHER AB (PUBL) SK-44 pay a dividend?
Dividend yield is not available in the current snapshot for GABATHER AB (PUBL) SK-44 (5J2). Check the MyAverix Finance app for the latest dividend data.
What sector is GABATHER AB (PUBL) SK-44 in?
GABATHER AB (PUBL) SK-44 (5J2) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 5J2 listed on?
5J2 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.